The Gross Margin of Mirati Therapeutics Inc (MRTX) is 95.18%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2022-12-31 | 95.18% |